Ebola drug companies are working overtime to search, develop and release a cure over the Ebola outbreak that has claimed thousands of lives. In China alone, an experimental drug is in its final stages for development to help cure Ebola. Another Ebola experimental drug had proven effective in a 7-year old boy close to dying from a viral infection in Virginia.
A company in China part owned by private equity funds of Morgan Stanley is in the final stages of its Ebola treatment. On Wednesday, Sihuan Pharmaceutical claimed they have created a drug out of 15 experimental drugs that has showed great success in clinical tests against the Ebola virus. Ebola drug companies are not only working on a treatment but on a vaccine as well. A number of vaccines are currently under evaluation for its efficacy and safety.
"We will work together . . . to bring the drug to the market as soon as possible," stated Dr Che Fengsheng, Sihuan Pharmaceuticals chief executive and chairman, in an exclusive report by the Financial Times.
Other than the Ebola drug companies in China, one experimental drug that proved effective in treating a viral infection had been administered to a 7-year old boy in Virginia. Chimerix, a biotechnology company, had given their experimental drug to Josh Hardy who was close to dying from a viral infection.
Now, the same Ebola experimental drug has been used as an emergency treatment for the Ebola-infected patient in Dallas and the cameraman of Nebraska. Notable, the drug created by the Ebola drug company had not once tested it on Ebola infected victims.
Ebola drug companies have tested a number of their drugs on animals. One is Tekmira Pharmaceuticals that made an experimental drug that protected monkeys from the Ebola virus. The same treatment was used on an American worked in Liberia who had been struck by Ebola.
This article is copyrighted by Travelers Today, the travel news leader
